Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9(12):886–96.

Article  CAS  PubMed  Google Scholar 

Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms. Nat Rev Mol Cell Biol. 2020;21(2):67–84.

Article  CAS  PubMed  Google Scholar 

Hastings MH, Maywood ES, Brancaccio M. Generation of circadian rhythms in the suprachiasmatic nucleus. Nat Rev Neurosci. 2018;19(8):453–69.

Article  CAS  PubMed  Google Scholar 

Crnko S, Du Pré BC, Sluijter JPG, Van Laake LW. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat Rev Cardiol. 2019;16(7):437–47.

Article  PubMed  Google Scholar 

Tagliabue G, Borgini A, Tittarelli A, van Donkelaar A, Martin RV, Bertoldi M, et al. Atmospheric fine particulate matter and breast cancer mortality: a population-based cohort study. BMJ Open. 2016;6(11):e012580.

Article  PubMed  PubMed Central  Google Scholar 

Rivera AS, Akanbi M, O’Dwyer LC, McHugh M. Shift work and long work hours and their association with chronic health conditions: a systematic review of systematic reviews with meta-analyses. PLoS ONE. 2020;15(4):e0231037.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erren TC, Falaturi P, Morfeld P, Knauth P, Reiter RJ, Piekarski C. Shift work and cancer: the evidence and the challenge. Dtsch Arztebl Int. 2010;107(38):657–62.

PubMed  PubMed Central  Google Scholar 

Shafi AA, Knudsen KE. Cancer and the circadian clock. Cancer Res. 2019;79(15):3806–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin HH, Farkas ME. Altered circadian rhythms and breast cancer: from the human to the molecular level. Front Endocrinol. 2018;9:219.

Article  Google Scholar 

Gery S, Virk RK, Chumakov K, Yu A, Koeffler HP. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene. 2007;26(57):7916–20.

Article  CAS  PubMed  Google Scholar 

Xiao L, Chang AK, Zang MX, Bi H, Li S, Wang M, et al. Induction of the CLOCK gene by E2-ERα signaling promotes the proliferation of breast cancer cells. PLoS ONE. 2014;9(5):e95878.

Article  PubMed  PubMed Central  Google Scholar 

Pan D, Kocherginsky M, Conzen SD. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011;71(20):6360–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92(12):994–1000.

Article  CAS  PubMed  Google Scholar 

Spörl F, Korge S, Jürchott K, Wunderskirchner M, Schellenberg K, Heins S, et al. Krüppel-like factor 9 is a circadian transcription factor in human epidermis that controls proliferation of keratinocytes. Proc Natl Acad Sci. 2012;109(27):10903–8.

Article  PubMed  PubMed Central  Google Scholar 

Yoshitane H, Ozaki H, Terajima H, Du NH, Suzuki Y, Fujimori T, et al. CLOCK-controlled polyphonic regulation of circadian rhythms through canonical and noncanonical E-boxes. Mol Cell Biol. 2014;34(10):1776–87.

Article  PubMed  PubMed Central  Google Scholar 

Knoedler JR, Ávila-Mendoza J, Subramani A, Denver RJ. The Paralogous Krüppel-like factors 9 and 13 regulate the mammalian cellular circadian clock output gene Dbp. J Biol Rhythms. 2020;35(3):257–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bagamasbad PD, Bonett RM, Sachs L, Buisine N, Raj S, Knoedler JR, et al. Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module. Mol Endocrinol. 2015;29(6):856–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mostafa MM, Bansal A, Michi AN, Sasse SK, Proud D, Gerber AN, et al. Genomic determinants implicated in the glucocorticoid-mediated induction of KLF9 in pulmonary epithelial cells. J Biol Chem. 2020;296:100065.

Article  PubMed  PubMed Central  Google Scholar 

Velarde MC, Zeng Z, McQuown JR, Simmen FA, Simmen RC. Kruppel-like factor 9 is a negative regulator of ligand-dependent estrogen receptor alpha signaling in Ishikawa endometrial adenocarcinoma cells. Mol Endocrinol. 2007;21(12):2988–3001.

Article  CAS  PubMed  Google Scholar 

Bai XY, Li S, Wang M, Li X, Yang Y, Xu Z, et al. Krüppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion. Cancer Lett. 2018;412:224–35.

Article  CAS  PubMed  Google Scholar 

Zhang XL, Zhang D, Michel FJ, Blum JL, Simmen FA, Simmen RC. Selective interactions of Kruppel-like factor 9/basic transcription element-binding protein with progesterone receptor isoforms A and B determine transcriptional activity of progesterone-responsive genes in endometrial epithelial cells. J Biol Chem. 2003;278(24):21474–82.

Article  CAS  PubMed  Google Scholar 

RRID:CVCL_0598. https://web.expasy.org/cellosaurus/CVCL_0598.

RRID:CVCL_0031. https://web.expasy.org/cellosaurus/CVCL_0031.

RRID:CVCL_0062. https://web.expasy.org/cellosaurus/CVCL_0062.

Qu Y, Han B, Yu Y, Yao W, Bose S, Karlan BY, et al. Evaluation of MCF10A as a reliable model for normal human mammary epithelial cells. PLoS ONE. 2015;10(7):e0131285.

Article  PubMed  PubMed Central  Google Scholar 

Lauriola M, Enuka Y, Zeisel A, D’Uva G, Roth L, Sharon-Sevilla M, et al. Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. Nat Commun. 2014;5:5073.

Article  CAS  PubMed  Google Scholar 

Perez Kerkvliet C, Dwyer AR, Diep CH, Oakley RH, Liddle C, Cidlowski JA, et al. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer. Breast Cancer Res. 2020;22(1):39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comşa Ş, Cîmpean AM, Raica M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res. 2015;35(6):3147–54.

PubMed  Google Scholar 

Zheng A, Kallio A, Härkönen P. Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. Endocrinology. 2007;148(6):2764–77.

Article  CAS  PubMed  Google Scholar 

Perrot-Applanat M, Di Benedetto M. Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion. Cell Adh Migr. 2012;6(6):547–53.

Article  PubMed  PubMed Central  Google Scholar 

Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015;5(10):2929–43.

CAS  PubMed  PubMed Central  Google Scholar 

Hiraga T, Ito S, Nakamura H. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential. Oncol Rep. 2011;25(1):289–96.

CAS  PubMed  Google Scholar 

Mojica CAR, Ybañez WS, Olarte KCV, Poblete ABC, Bagamasbad PD. Differential glucocorticoid-dependent regulation and function of the ERRFI1 gene in triple-negative breast cancer. Endocrinology. 2020;161(7):bqaa082.

Article  PubMed  PubMed Central  Google Scholar 

GTEx Consortium. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580–5.

Article  Google Scholar 

Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113–20.

Article  PubMed  PubMed Central  Google Scholar 

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98-w102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jézéquel P, Gouraud W, Ben Azzouz F, Guérin-Charbonnel C, Juin PP, Lasla H, et al. bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database: J Biol Database Curation. 2021;2021:baa007.

Article  Google Scholar 

Saal LH, Vallon-Christersson J, Häkkinen J, Hegardt C, Grabau D, Winter C, et al. The Sweden Cancerome Analysis Network-Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 2015;7(1):20.

Article  PubMed  PubMed Central  Google Scholar 

Baran-Gale J, Purvis JE, Sethupathy P. An integrative transcriptomics approach identifies miR-503 as a candidate master regulator of the estrogen response in MCF-7 breast cancer cells. RNA. 2016;22(10):1592–603.

Article  CAS  PubMed